SlideShare uma empresa Scribd logo
1 de 38
Baixar para ler offline
Financial Resource
               Requirements
                  2012–2013
                               As as 1 February2012
                                  of of 1 May 2012




 PARTNERS IN THE GLOBAL
POLIO ERADICATION INITIATIVE
global polio eradication initiative




     © World Health Organization 2012

     All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased
     from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857;
     e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial
     distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index.
     html).

     The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on
     the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning
     the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full
     agreement.

     The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the
     World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of
     proprietary products are distinguished by initial capital letters.

     All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.
     However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the
     interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising
     from its use.

     Photo front cover: WHO/Frederic Caillet - Children in a polio-free India. On 12 January 2012, India passed the one year mark without polio
     for the first time in history. If all pending laboratory investigations return negative in the coming weeks, India will officially be deemed to
     have stopped indigenous wild poliovirus. The numbers of polio-endemic countries would be reduced to three: Pakistan, Afghanistan and
     Nigeria.

     Photo back cover: WHO/Sona Bari. Children during an SIA in March 2012 in Islamabad, Pakistan. Pakistan remains one of the three
     endemic countries. Persistent wild poliovirus transmission is restricted to three groups of districts: (1) Karachi city, (2) a group of districts
     in Balochistan Province, and (3) districts in the Federally Administered Tribal Areas (FATA) and the North-West Frontier Province. The
     Government of Pakistan and partners have launched an informative new website outlining the latest in the country’s polio eradication effort.
     The website is www.Endpolio.com.pk.

     Design: philippecasse.ch
     Layout: Paprika-annecy.com
global polio eradication initiative                  1

                                                                                                                                           WHO/POLIO/12.04




Table of Contents
1 |	 Executive summary .......................................................................................................................3

2 |	 Financial Resource Requirements 2012-2013 .......................................................................6

3 |	Roles and Responsibilities of Spearheading Partners . ...............................................7

4 |	Definition of the GPEI Activities and Budget Estimates .................................................7

5 |	Polio Research . ...........................................................................................................................14

6 |	Review of the GPEI Budgets and Allocation of Funds . .................................................15

7 |	 Donors . ...........................................................................................................................................16

8 |	Annexes ..........................................................................................................................................17




                                                                                            Financial Resource Requirements 2012–2013 | As of 1 may 2012
2   global polio eradication initiative




           Acronyms and abbreviations

           AusAID	     Australian Government Overseas Aid Program

           AFP	        Acute flaccid paralysis

           BMGF	       Bill & Melinda Gates Foundation

           bOPV	       Bivalent oral polio vaccine

           CDC	        US Centers for Disease Control and Prevention

           CIDA	       Canadian International Development Agency

           DFID	       UK Department for International Development

           EAP	        Global Polio Emergency Action Plan

           FRR	        Financial Resource Requirements

           GPEI	       Global Polio Eradication Initiative

           JICA	       Japan International Cooperation Agency

           mOPV	       Monovalent oral polio vaccine

           NIDs	       National Immunization Days

           OPV	        Oral polio vaccine

           PSC	        Programme support costs

           SIAs	       Supplementary Immunization Activities

           SNIDs	      Sub-national Immunization Days

           tOPV	       Trivalent oral polio vaccine

           UNICEF	 United Nations Children’s Fund

           USAID	      United States Agency for International Development

           VAPP	       Vaccine-associated paralytic polio

           VDPV	       Vaccine-derived poliovirus

           WHO	        World Health Organization

           WPV	        Wild poliovirus




    Financial Resource Requirements 2012–2013 | As of 1 may 2012
global polio eradication initiative                      3




1 | Executive summary
The– Financial Resourcerequired andbycurrently(FRR)
   details the funding –
                          Requirements series
                                               avail-
able to finance activities identified the Global Polio
                                                                                      While a new Global Polio Emergency Action Plan 2012-
                                                                                      2013 (EAP) is being developed to address the critical
                                                                                      programmatic risks, urgent additional investments are
Eradication Initiative (GPEI) for the 2012-2013 period                                essential to tip it towards success. With the lowest-ever
to interrupt wild poliovirus transmission globally and                                number of polio cases reported for the first quarter of
prepare for the post-eradication era. The FRR is updated                              2012, in just four countries, success has never been
quarterly. Programmatic and financial scenarios for the                               closer.
polio eradication endgame (i.e. for 2014-2018) will be
presented in an upcoming edition of the FRR. This edi-                                In January 2012, the WHO Executive Board declared that
tion of the FRR summarizes financial developments in the                              the completion of polio eradication must now be treated
past quarter in the relevant epidemiological context.                                 as a “programmatic emergency for global public health.”
                                                                                      Following this declaration the EAP has been developed,
                                                                                      and will be discussed at the World Health Assembly in
The 2012-2013 budget estimate for core costs, planned                                 May 2012. The EAP represents an urgent escalation of
supplementary immunization activities and emergency                                   national and international efforts using a wide range of
response is US$ 2.19 billion, against which there is a                                new targeted and cross-cutting initiatives to eradicate
funding gap of US$ 945 million (US$ 270 million for                                   polio, and enhanced resource mobilization to bridge the
2012). The Initiative is tracking US$ 344 million in firm                             Initiative’s critical funding gap.
prospects; if donors fulfil these commitments, then the
overall funding gap for 2012-2013 is reduced to US$ 601                               The over-riding goal of the EAP is to help the remaining
million.                                                                              polio-infected areas of Nigeria, Pakistan and Afghanistan
                                                                                      get back on track for eradication through an emergency
The budget estimate of US$ 2.19 billion represents a                                  approach with appropriate leadership, oversight and ac-
decrease of US$ 44 million compared to earlier estimates,                             countability, and bolstered by an extensive surge of tech-
driven primarily by the cancellation or reduction of                                  nical assistance down to the subnational level. The emer-
supplementary immunization activities (SIAs) in 24 high                               gency activities are driven by the national governments
risk polio-free countries across west, central and the Horn                           of the endemic and re-established transmission countries,
of Africa as well as Central Asia in the first half of 2012.                          with support from international partners. The EAP builds
Additional cuts in SIAs will have to be instituted in the                             upon the approaches outlined in the GPEI Strategic Plan
second half of 2012 should the required funding not be                                2010-2012 and is designed to accelerate progress towards
available. The revised budget estimate does include an                                the realization of its milestones. The EAP will also serve
increase in surge capacity, primarily for Nigeria. New                                as a precursor to the endgame strategy for 2014-2018.
contributions of US$ 98 million for 2012-2013, received
since February 2012 from Angola, Bangladesh, Bill &                                   In its February 2012 report, the Independent Monitoring
Melinda Gates Foundation, Canada, Japan and Nigeria,                                  Board of the GPEI (IMB) congratulated the Indian govern-
help to offset this increase.                                                         ment and its partners on that country’s “magnificent”
                                                                                      milestone.1 However, the IMB was extremely concerned at
Table 1 | GPEI 2012-2013 Budget, as at May 2012                                       the increase in polio transmission in Nigeria and Pakistan,
(all figures in US$ millions)                                                         stating that together, these two countries now constitute
                                                                                      the most potent threat to global eradication.
 Budget, as at February                                           2,232.00
                                                                                      During its April meeting, the Strategic Advisory Group of
 Budget Decreases                                                    -44.00
                                                                                      Experts on immunization (SAGE) carefully reviewed the
 New Budget                                                       2,188.00            country-specific national polio emergency action plans for
                                                                                      Nigeria, Pakistan and Afghanistan. They expressed seri-
 Gap, as at February                                              1,089.00            ous alarm at the funding situation, and strongly appealed
 Budget Decreases                                                    -44.00           for donor and government support, highlighting that a
                                                                                      continued funding crisis will rule out the full implemen-
 New Contributions                                                   -98.00           tation of the emergency plans. SAGE also requested the
 New Gap (Rounded)                                                  945.00            polio partners to submit by November 2012 a strategic
                                                                                      plan and budget for the 2014-2018 endgame period.
                                                                                      In recent months, special efforts have been made to
The Director-General of the World Health Organization                                 recognize leaders in the fight to “End Polio Now.” On
has described the current state of polio eradication as                               14 March, United Kingdom (UK) Prime Minister David
being at “a tipping point between success and failure.”                               Cameron was recognized by Rotary International as a

1	 As of 28 February 2012, India is no longer considered to be a polio-endemic country. For the purposes of the current FRR, it is considered “recently-endemic”.
2	The Polio Eradication Champion Award is the highest honour Rotary presents to heads of state, health agency leaders and others who have made significant contributions
   to the global polio eradication effort.
                                                                                                    Financial Resource Requirements 2012–2013 | As of 1 may 2012
4   global polio eradication initiative




           Polio Eradication Champion2, for his leadership and dedi-     The newly constituted Global Polio Partners’ Group
           cation to a polio-free world, and for announcing in 2011      (PPG) of GPEI, which serves as the “stakeholder voice”
           a doubling of the UK’s funding for the next two years in a    in the polio program, met for the first time in Geneva
           challenge grant. “We have a once-in-a-generation oppor-       on 11 April 2012. The meeting brought together do-
           tunity to rid the world of the evil of polio,” said Cameron   nors and other financing and advocacy partners to dis-
           in a statement. “The commitment of Britain and the            cuss the EAP, the IMB report and opportunities to close
           Global Polio Eradication Initiative, with the support of      the critical funding gap. The PPG also discussed the
           millions of Rotarians, has helped bring this crippling and    ongoing work around the polio eradication endgame
           often deadly disease to the brink of eradication.”            plan for 2014-2018 as well as the long-term financing
                                                                         requirements and mechanisms.
           On 23 April, Rotary International’s incoming chair
           of the Rotary Foundation Board of Trustees, Wilfrid           As the GPEI works with Governments to fully and effec-
           Wilkinson, presented Nigerian President Goodluck              tively implement the EAP, additional funding is urgently
           Jonathan with the award in recognition of his contin-         needed to close the funding gap of US$ 945 million to
           ued political and increasing financial support for polio      conduct planned polio immunization activities in 2012-
           eradication. Nigeria has to date disbursed US$ 12.7           2013, and also support the longer term financing needs
           million of the US$ 30 million per year pledge made by         for 2014-2018. The GPEI, through the Polio Advocacy
           President Jonathan at the October 2011 Commonwealth           Group (PAG), seeks to work closely with all donors to
           Heads of Government meeting in Perth, Australia.              mobilize the needed financial resources. In this regard,
                                                                         additional approaches will be made to the G8, the
           Rotarians and Rotary International continue to provide        G20, the BRICS group of nations, member states of the
           extraordinary support, and in May announced that they         Organization of Islamic Cooperation (OIC), multilateral
           had raised US$ 215 million towards the Bill & Melinda         financial institutions and regional development banks,
           Gates Foundation’s US$ 200 million challenge.                 private citizens and the private sector.


           Table 2 | Summary of external resource requirements by major category of activity, 2012–2013
           (all figures in US$ millions)
            CORE COSTS                                                            2012                 2013          2012-2013
            Emergency Response (OPV)                                             $16.50               $20.00           $36.50
            Emergency Response (Ops)                                             $40.00               $25.00           $65.00
            Emergency Response (Soc Mob)                                          $4.50                $6.00           $10.50
            Surveillance and Running Costs (Incl. Security)                      $61.82               $64.36          $126.18
            Surge Capacity                                                       $35.00                $0.00           $35.00
            Laboratory                                                           $11.08               $11.23           $22.31
            Technical Assistance (WHO)                                          $134.04              $136.57          $270.61
            Technical Assistance (UNICEF)                                        $35.62               $37.31           $72.94
            Certification and Containment                                         $5.00                $5.00           $10.00
            Product Development for OPV Cessation                                $10.00               $10.00           $20.00
            Post-eradication OPV Stockpile                                       $12.30                $0.00           $12.30

            SUPPLEMENTARY IMMUNIZATION ACTIVITIES                                 2012                 2013          2012-2013
            Oral Polio Vaccine                                                  $301.73              $285.63          $587.36
            NIDs/SNIDs Operations (WHO-Bilateral)                               $323.44              $248.39          $571.83
            NIDs/SNIDs Operations (UNICEF)                                       $28.33               $28.15           $56.48
            Social Mobilization for SIAs                                         $87.63               $93.68          $181.32

            Subtotal                                                          $1 107.00             $971.32         $2 078.32
            Programme Support Costs (estimated)*                                 $56.98              $52.49          $109.47

            GRAND TOTAL                                                       $1 163.98            $1 023.81        $2 187.79
            Contributions                                                      $891.70              $349.11         $1 240.81
            Funding Gap                                                        $272.28              $674.70          $946.98
            Funding Gap (rounded)                                              $270.00              $675.00          $945.00
           * Programme Support Cost (PSC) estimates are calculated based on sources and channel of funds

    Financial Resource Requirements 2012–2013 | As of 1 may 2012
global polio eradication initiative                 5




Figure 1 | Annual expenditure 1988-2011, contributions and funding gap 2012-2013
(all figures in US$ millions)

1400


1200
           1988-2011
           Total expended: US$ 9.03 billion
1000

           2012
800        Funding Gap: US$ 270 million

           2013
           Funding Gap: US$ 675 million
600


400


200


0
    1988 1989 1990 1991 1992 19931993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    1988
          1989 1990 1991 1992

    EXPENDITURE          CASH OR PLEDGED          FUNDING GAP




Figure 2 | Financing 2012-2013, US$1.24 billion contributions
            Financing 2012-2013, US$ 1.24 billion in contributions


                                                                                           G8 14%
                                                        Canada     USAID CDC
             Multilateral                  JICA Loan
                                                         Japan                        UK      Russian Federation
             Sector 6%                    Conversion
                                            UNICEF                                             EC
                                              WHO                                               Bangladesh
                                              IFFIm                                                      India                     Domestic
                                       World Bank                                                                                  Resources
                                                                                                                                   20%
             Private               Bill & Melinda
                                Gates Foundation
             Sector 15%                                                                                     Nigeria
                              Rotary International                                                           Angola
                                                                                                             Australia
                                                                                                                 Luxembourg
                                                                                                           Others

                                                                                                                                   Non-G8
                                                                                                                                   OECD/
                                                                                                                                   Other 2%
    Current Funding Gap: US$ 945 m of US$ 2.19 b budget
         Firm Prospects: US$ 344 m
         Best Case Gap: US$ 601 m


‘Other’ includes: Austria, Brunei Darussalam, Finland, Monaco, Nepal, Central Emergency Response Fund (CERF), Common Humanitarian Fund (South Sudan),
and Google Foundation/Matching Grant.



                                                                                       Financial Resource Requirements 2012–2013 | As of 1 may 2012
6   global polio eradication initiative




         2 | Financial Resource Requirements
         	 2012–2013
         This Financial Resource Requirements (FRR) outlines                                                 The FRR is updated regularly based on evolving epide-
         the budget to implement the core strategies to stop                                                 miology; this is the second issue of the year3. Financial
         polio and to institutionalize innovations to improve the                                            requirements detailed here represent country require-
         quality of intensified SIAs, increase technical assistance                                          ments and are inclusive of agency (i.e. WHO and
         to countries with re-established polio transmission,                                                UNICEF) overhead costs.
         enhance surveillance, systematize the synergies be-
         tween immunization systems and polio eradication and                                                Endemic/recently-endemic countries account for 67%
         expand pre-planned vaccination campaigns across the                                                 of the country budgets; countries with re-established
         “WPV importation belt” of sub-Saharan Africa. Filling                                               transmission for 15%; and, other importation-affected
         sub-national surveillance gaps, revitalizing surveillance                                           countries for 18%.
         in polio-free Regions, implementing new global surveil-
         lance strategies and intensifying social mobilization                                               Just as high-cost control of polio transmission is not
         work are also costed in the 2012–2013 budget.                                                       sustainable, low-cost control is not effective, since de-
                                                                                                             pending on routine immunization alone would lead to
         As the new Global Polio Emergency Action Plan 2012–2013                                             200,000–250,000 cases per year. Neither scenario is
         (EAP) is finalized, the Initiative is working under an                                              optimal when eradication is feasible4. Previous cost-effec-
         emergency operating framework. The financial require-                                               tiveness studies5 have demonstrated that US$ 10 billion
         ments outlined in this document reflect the strategic and                                           would be needed over a 20-year period to simply
         geographic priorities of the framework as well as the                                               maintain polio cases at current levels, in contrast to the
         continued implementation of key activities of the Strate-                                           US$ 2.19 billion presented here. Financial modelling in
         gic Plan. The financial requirements incorporate the full                                           20106 estimated the financial benefits of polio eradica-
         scope of the Emergency Plan.                                                                        tion at US$ 40–50 billion. Most of those savings (85%)
                                                                                                             are expected in low-income countries.
         Figure 3 | Comparison of budgets of countries conducting SIAs in 2012 (as a % of country-level costs)

                     Polio-endemic/
                    Recently-endemic
             $350    countries 67%



             $300   34%




             $250



             $200



             $150         16%
                                            Re-established                                                    Countries with                                               Other importation-
                                13%          transmission                                                 recurrent importations                                           affected countries
                                                 15%                                                               16%                                                             2%
             $100


                           12%
             $50
                                      4%


             $0
                                                                    i er                 lia nya nda nea nin ana oon gal                                                          l     ar rde
                      dia eria stan stan ngo gola had dan dan     al         ia  re   so                                          en blic one eria ania ogo ngo sau bia esh epa
                    In                                           M Nig hiop 'Ivoi Fa ma              i  Be Gh    er ene Yem epu Le Lib                                                sc   e
                           g   i     i
                         Ni Pak han R C
                                         o
                                            An    C  Su     Su                              Ke Uga Gu                                              rit  T Co        s
                                                                                                                                                                  Bi Gam gla
                                                                                                                                                                            d N     ga e V
                                                          h              Et te d kina So                       am   S               R  rra       au            ea                da ap
                                   g   D                ut                                                                                                              Ba
                                                                                                                                                                          n
                                 Af                   So                   Cô Bur                             C
                                                                                                                                can Sie        M
                                                                                                                                                            uin                M
                                                                                                                                                                                a      C
                                                                                                                             fri                           G
                                                                                                                           lA
                                                                                                                        tra
                                                                                                                    C en

         3	 While the FRR provides overall budget estimates, detailed budgets are available upon request.
         4	 Barrett S, Economics of eradication vs control of infectious diseases, Bulletin of the WHO, Volume 82, Number 9, September 2004, 639-718. http://www.who.int/bul-
            letin/volumes/82/9/en/index.html
         5	 Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007; 369(9570): 1363-71.
         6	 Tebbens RD, et al. The Economic analysis of the global polio eradication initiative. Vaccine 2010, doi:10.1016/j.vaccine.2010.10.25.
global polio eradication initiative                   7




3 | Roles and Responsibilities
	 of Spearheading Partners
The spearheading partners of the GPEI are the World                                  WHO is responsible for the systematic collection, colla-
Health Organization (WHO), Rotary International, the                                 tion and dissemination of standardized information on
US Centers for Disease Control and Prevention (CDC)                                  strategy implementation and impact, particularly in the
and UNICEF Rotary International is the leading private-
              .                                                                      areas of surveillance and supplementary immunization
sector donor to polio eradication, advocates with govern-                            activities.
ments and communities and provides field-level support
in SIA implementation and social mobilization. CDC de-                               WHO also leads operational and basic research, pro-
ploys a wide range of public health assistance in the form                           vides technical and operational support to ministries of
of staff and consultants, provides specialized laboratory                            health, and coordinates training and deployment of hu-
and diagnostic expertise and contributes funding.                                    man resources for supplementary technical assistance.
                                                                                     WHO also serves as secretariat to the certification
UNICEF is the lead partner in support of communica-                                  process and facilitates implementation and monitoring
tions and social mobilization, and in the procurement                                of biocontainment activities.
and distribution of oral polio vaccine for supplemen-
tary immunization activities. UNICEF also works with                                 The budgets that underpin the FRR are prepared by
partners to strengthen routine immunization, including                               WHO, UNICEF and the national governments that
support to cold chain and vaccine distribution mecha-                                manage the polio eradication activities. The funds to
nisms at national and sub-national levels.                                           finance the activities flow from multiple channels,
                                                                                     primarily through these stakeholders. Both UN agen-
                                                                                     cies support the governments in the preparation and
                                                                                     implementation of SIAs.



4 | Definition of the GPEI Activities
	 and Budget Estimates
A robust system of estimating costs drives the develop-                              up for SIAs at the local level and take into consideration
ment of the global budget estimates from the micro-                                  local costs for all elements of an activity – trainings,
level up. A schedule for SIAs is drawn up based on                                   community meetings, posters, announcements, vaccina-
the guidance of national Technical Advisory Groups                                   tor payments, vehicles, fuel, supplies, etc.
(TAGs), Ministries of Health and the country offices of
WHO and UNICEF In 2011, for example, more than
                    .                                                                4.1. Cost Drivers of the GPEI Budget
2.35 billion doses of OPV were administered to more                                  The key cost drivers of the GPEI budget are OPV and
than 430 million children during 300 polio vaccination                               SIA operations, followed by technical assistance, social
campaigns in 54 countries7.                                                          mobilization and surveillance8 (See Table 2).

The recommended schedule of SIAs is used by national                                 4.1.1. Oral polio vaccine
governments, working with WHO and UNICEF to de-,                                     UNICEF is the agency that procures vaccine for the
velop budget estimates. These are based on plans drawn                               GPEI, and works to ensure OPV supply security (with

7	 In 2011, OPV was given during 144 National Immunization Days, 129 Sub-national Immunization Days, 10 mop-up campaigns and 17 Child Health Days. Children
   may have received more than one dose of OPV.
8	 For 2012-2013, for example, OPV accounts for 29% of the budget, operations for 32%, technical assistance for 16%, social mobilization for 9% and surveillance for
   6%, with the remainder being dedicated to emergency response, surge capacity, laboratories, research activities, etc.

                                                                                                   Financial Resource Requirements 2012–2013 | As of 1 may 2012
8   global polio eradication initiative




           multiple suppliers), at a price that is both affordable                                US$ 0.14 per dose since 2000. The flexibility of manu-
           to governments and donors and reasonably covers the                                    facturers, to adjust production based on the OPV for-
           minimum needs of manufacturers. In 2011, more than                                     mulation required, comes at a cost. Currency fluctua-
           1.6 billion doses of OPV were required for activities in                               tions, the demand for high titres and the finite lifespan
           areas with active poliovirus transmission.                                             of OPV – for which demand will drop after the eradica-
                                                                                                  tion of polio – also contribute to this price increase.
           Since 2005 the supply landscape has become more
           complex with the introduction of two types of monova-                                  Despite these factors, the weighted average price of
           lent OPV (types 1 and 3) and, in 2010, bivalent OPV.                                   each OPV dose in 2011 (US$ 0.128) and 2012
           This has contributed to a rise in the weighted average                                 (US$ 0.127) show decreases since 2010.
           price of OPV from US$ 0.08 per dose to approximately

            Figure 4 | OPV supply and weighted average price, 2000–2012

                            3,000                                                                                                 0.18

                                                                                                                                  0.16
                            2,500
                                                                                                                                  0.14

                            2,000                                                                                                 0.12




                                                                                                                                         US$ PRICE PER DOSE
           MILLIONS DOSES




                                                                                                                                   0.1
                                                                                                                                                              tOPV
                            1,500
                                                                                                                                  0.08
                                                                                                                                                              mOPV1
                            1,000                                                                                                 0.06

                                                                                                                                                              mOPV3
                                                                                                                                  0.04
                            500
                                                                                                                                  0.02                        bOPV

                            0                                                                                                        0                        WAP
                                    2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012




           4.1.2. Operations costs                                                               Major factors affecting operations costs are the rela-
           SIAs are vast operations to deliver vaccine to every                                  tive strength of the local infrastructure – whether it be
           household: micro-plans have to be drawn up or updat-                                  roads, telecommunications or any of a host of facilities
           ed for every dwelling in the area to be covered, whether                              – and the local health system, the local economy, avail-
           a single district or an entire country. Vaccine has to be                             ability of semi-skilled workers, security conditions and
           delivered to distribution centres throughout the target                               population density. In 2011, 1.44 million paid vaccina-
           area. Vaccinators have to be trained to vaccinate chil-                               tors worked in SIAs; vaccinator per diems – to cover
           dren and mark fingers and houses, to document their                                   basic needs such as food and transport – constitute a
           work, to report their activities, to communicate with                                 large portion of operations costs9.
           families appropriately, and so on. Vaccinators have to
           visit every household; supervisors and monitors have to
           scour every street for unvaccinated children.


           9	 Based on local rates for semi-skilled labour and government remuneration for similar tasks.



    Financial Resource Requirements 2012–2013 | As of 1 may 2012
global polio eradication initiative               9




Figure 5 | Operations costs per child for SIAs, 2012 (all figures in US$, excluding PSC)

$ 1.00

$ 0.90 Polio-endemic/
      Recently-endemic   Re-established                         Countries with                              Other importation-
          countries       transmission                      recurrent importations                          affected countries
$ 0.80

$ 0.70

$ 0.60

$0.50

$ 0.40

$ 0.30

$ 0.20

$ 0.10

$ 0.00




                        sh
           ng al
                        an
           Ta on
              m o
                         a
                         a
               Gu n
                        da
              Ug li
                       ire
           te so
                          r
                       pia
             Et ia
             So al
             Se o
                       au
            a B ya
                       bia
              Ga ia
               Li e
            ra ep.
            ca e
  nt Cap ania
            au o
          DR la
              An n
                       ad
                         n
          ut dia
                         n
                       ria
              Ni n




                     ige




                        a




          Ca Tog
                     an
                    ine
                       ni
                     ng
                     on
         fri erd
         M ong
                    da
                    da
                      ta
                       a




        Ba Nep
                      al
                       r




                      g
                   go




        ine en




                    M




                   de
        Cô a Fa




                   ist
                      o
                   an
                   vo
                  iss
                 Ch




                  be
                  ist
                 ge




                 hio




                 Be
                  m




                 ne
       Si n R
       So In
                kis




                 er
                 m




                Gh
                Co
                Le




      Bu N
                Su
               Su




                rit
              eV




               d'I




               jik
     Gu K




                la
              an




               C
            Pa




             in
             h
          gh




          rk
         er
        Af




      lA
    ra
Ce




4.1.3. Surveillance
Surveillance budgets cover the detection and reporting      Some of the other activities included under surveil-
of acute flaccid paralysis (AFP) cases, through both an     lance budget lines are the training of personnel to carry
extensive informant network of people who first report      out each of the steps outlined above, as well as regular
cases of AFP and active searches in health facilities for   reviews of the surveillance systems and the purchase
such cases. Subsequent case investigation is followed       and maintenance of equipment, from photocopiers to
by collection of two stool samples, transportation to       vehicles. In locations where there are security risks for
the appropriate laboratory, testing and genetic sequenc-    polio staff, items such as armoured vehicles and appro-
ing, the range of activities related to the management of   priate communication equipment may be included in
the information and data generated. The Global Polio        the surveillance budgets. The average cost per AFP case
Laboratory Network comprises 146 facilities, which in       reported dropped from a high of more than US$ 1,500
2011 tested over 206,000 stool samples (from nearly         in the year 2000, when there was heavy investment in
96,000 cases of AFP and other sources).                     establishing the infrastructure for AFP surveillance to ap-
                                                            proximately US$ 581 in 2010. The range among coun-
                                                            tries in cost per AFP case investigated is based on factors
                                                            similar to those which affect differences in SIA costs.




                                                                        Financial Resource Requirements 2012–2013 | As of 1 may 2012
10   global polio eradication initiative




            Figure 6 | Surveillance cost per AFP case analysis, 2011 (all figures in US$)*

            $ 9,000

                                                                                                                                                                     Other
                       Polio-endemic/                                                                                                                            importation-
                      Recently-endemic       Re-established                                               Countries with                                            affected
                          countries           transmission                                            recurrent importations                                       countries


            $ 6,000




            $ 3,000




                $0




                                                                                                                                                                              l
                                                                                                                                                                     ea
                                                                                                                                                          en
                                                                                                                                                          ire
                                                                                                                                                            a
                                                                                                                                          da
                                                                                                                                           a
                                                                                                                                          so
                                                                                                                                            i
                                                                                                                        e
                                                                                                                        a
                                                                                                                      nin
                                                                                                        n
                                                                                                       go
                                                                                             r
                                                                       pia
                                                                        ia
                                                                        p.
                                                                        ia
                                                                       ria
                                                                         o
                                                                       ad
                                                 n
                                       la
                                      dia
                            n
                          an
                          ria




                                                                                                                                                                            pa
                                                                                                                                          al
                                                                                           ge




                                                                                                                                                         ny
                                                                                                                                        ine
                                                                                                                     on
                                                                                                                     an
                                                                                                      oo
                                                                      ng
                                               da
                         ta




                                                                     an
                                                                      al

                                                                     Re
                                     go




                                                                                                                                                                  itr
                                                                                                                                        M

                                                                                                                                       Fa




                                                                                                                                                        m
                                                                                                                                       an




                                                                                                                                                        vo
                                                                                                     To
                                                                    Ch
                       ist




                                                                    be




                                                                                                                                                                          Ne
                      ge




                                                                   hio




                                                                                                                   Be
                                    In




                                                                                                                                                      Ke
                     kis




                                                                                         Ni
                                                                    m




                                                                                                    er




                                                                                                                   Le
                                                                                                                   Gh
                                                                  Co
                                             Su




                                                                                                                                     Gu




                                                                                                                                                                Er
                                                                  rit




                                                                                                                                                     Ye
                                  An




                                                                                                                                                     d'I
                                                                                                                                    Ug
                    an




                                                                  n
                                                                  Li




                                                                                                                                   ina
                    Ni




                                                                 So




                                                                                                   m
                                                                 Et
                   Pa




                                                                au
                                                                ca




                                                                                                                ra
                                                       DR




                                                                                                                                                  te
                  gh




                                                                                                 Ca




                                                                                                                                 rk
                                                             fri




                                                                                                              er
                                                             M




                                                                                                                                                Cô
                Af




                                                                                                                               Bu
                                                           lA




                                                                                                            Si
                                                         ra
                                                       nt
                                                     Ce




            *Figures represent 80% of 2011 data.




            Figure 7 | Average cost per AFP case reported (AFR, EMR, SEAR) (all figures in US$)*

            2,000


                      $ 1,711

            1,500


                                                     $ 1,194
                                $ 1,096   $ 1,106              $ 1,128
            1,000
                                                                         $ 866
                                                                                 $ 815                           $772
                                                                                            $ 741      $ 722                $ 692
                                                                                                                                     $ 615
            500




            0
                      2000      2001      2002       2003      2004      2005    2006       2007       2008      2009       2010     2011

            *Adjusted for inflation (2011 US$).




     Financial Resource Requirements 2012–2013 | As of 1 may 2012
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013
Financial resource requirements 2012 2013

Mais conteúdo relacionado

Semelhante a Financial resource requirements 2012 2013

Institutional funding opportunities & strategies during Covid-19
Institutional funding opportunities & strategies during Covid-19Institutional funding opportunities & strategies during Covid-19
Institutional funding opportunities & strategies during Covid-19MzN International
 
The global eye health action plan 2014–2019
The global eye health action plan 2014–2019The global eye health action plan 2014–2019
The global eye health action plan 2014–2019Trinity Care Foundation
 
Global polio updates and hss (1)
Global polio updates and hss (1)Global polio updates and hss (1)
Global polio updates and hss (1)Dr. Suchitra Lisam
 
Global Polio Updates and HSS (1)
Global Polio Updates and HSS (1)Global Polio Updates and HSS (1)
Global Polio Updates and HSS (1)Dr. Suchitra Lisam
 
Rebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityRebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityTHL
 
Financial Preparedness and Investing during Pandemics
 Financial Preparedness and Investing during  Pandemics Financial Preparedness and Investing during  Pandemics
Financial Preparedness and Investing during PandemicsDr. Prachi Ugle Pimpalkhute
 
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptx
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptxLESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptx
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptxarifnasr
 
Investing_for_Results_2015
Investing_for_Results_2015Investing_for_Results_2015
Investing_for_Results_2015Vedant Batra
 
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19MzN International
 
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...Alternative approaches for sustaining the HIV and AIDS response in Dominican ...
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...HFG Project
 
Sustaining the HIV/AIDS Response in Dominica: Investment Case
Sustaining the HIV/AIDS Response in Dominica: Investment CaseSustaining the HIV/AIDS Response in Dominica: Investment Case
Sustaining the HIV/AIDS Response in Dominica: Investment CaseHFG Project
 
Css framework
Css frameworkCss framework
Css frameworkjselv
 
Financial Innovation Landscape Research: Testing the Feasibility of Financial...
Financial Innovation Landscape Research: Testing the Feasibility of Financial...Financial Innovation Landscape Research: Testing the Feasibility of Financial...
Financial Innovation Landscape Research: Testing the Feasibility of Financial...EveryWomanEveryChild
 
World Health Statistics 2022 by WHO
World Health Statistics 2022 by WHO World Health Statistics 2022 by WHO
World Health Statistics 2022 by WHO Muhammad Ali Jehangir
 
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004Dr Seán Doolan, MBA
 
Second quarter 2022 results
Second quarter 2022 results Second quarter 2022 results
Second quarter 2022 results Sanofi
 
Sustaining the HIV and AIDS Response in Grenada: Investment Case Brief
Sustaining the HIV and AIDS Response in Grenada: Investment Case BriefSustaining the HIV and AIDS Response in Grenada: Investment Case Brief
Sustaining the HIV and AIDS Response in Grenada: Investment Case BriefHFG Project
 

Semelhante a Financial resource requirements 2012 2013 (20)

Institutional funding opportunities & strategies during Covid-19
Institutional funding opportunities & strategies during Covid-19Institutional funding opportunities & strategies during Covid-19
Institutional funding opportunities & strategies during Covid-19
 
The global eye health action plan 2014–2019
The global eye health action plan 2014–2019The global eye health action plan 2014–2019
The global eye health action plan 2014–2019
 
Global polio updates and hss
Global polio updates and hssGlobal polio updates and hss
Global polio updates and hss
 
Global polio updates and hss (1)
Global polio updates and hss (1)Global polio updates and hss (1)
Global polio updates and hss (1)
 
Global Polio Updates and HSS (1)
Global Polio Updates and HSS (1)Global Polio Updates and HSS (1)
Global Polio Updates and HSS (1)
 
Rebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityRebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health Security
 
Financial Preparedness and Investing during Pandemics
 Financial Preparedness and Investing during  Pandemics Financial Preparedness and Investing during  Pandemics
Financial Preparedness and Investing during Pandemics
 
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptx
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptxLESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptx
LESSONS LEARNED – GLOBAL RESPONSE TO COVID-19 PANDEMIC.pptx
 
Investing_for_Results_2015
Investing_for_Results_2015Investing_for_Results_2015
Investing_for_Results_2015
 
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19
INSTITUTIONAL FUNDING AND FUNDING MODELS DURING & AFTER COVID-19
 
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...Alternative approaches for sustaining the HIV and AIDS response in Dominican ...
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...
 
Sustaining the HIV/AIDS Response in Dominica: Investment Case
Sustaining the HIV/AIDS Response in Dominica: Investment CaseSustaining the HIV/AIDS Response in Dominica: Investment Case
Sustaining the HIV/AIDS Response in Dominica: Investment Case
 
Css framework
Css frameworkCss framework
Css framework
 
Financial Innovation Landscape Research: Testing the Feasibility of Financial...
Financial Innovation Landscape Research: Testing the Feasibility of Financial...Financial Innovation Landscape Research: Testing the Feasibility of Financial...
Financial Innovation Landscape Research: Testing the Feasibility of Financial...
 
9 core global-fund_strategy_en1
9 core global-fund_strategy_en19 core global-fund_strategy_en1
9 core global-fund_strategy_en1
 
9 core global-fund_strategy_en1
9 core global-fund_strategy_en19 core global-fund_strategy_en1
9 core global-fund_strategy_en1
 
World Health Statistics 2022 by WHO
World Health Statistics 2022 by WHO World Health Statistics 2022 by WHO
World Health Statistics 2022 by WHO
 
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004
India Healthcare RCH2 - Sean Doolan & Ruma Tavorath, Oct 2004
 
Second quarter 2022 results
Second quarter 2022 results Second quarter 2022 results
Second quarter 2022 results
 
Sustaining the HIV and AIDS Response in Grenada: Investment Case Brief
Sustaining the HIV and AIDS Response in Grenada: Investment Case BriefSustaining the HIV and AIDS Response in Grenada: Investment Case Brief
Sustaining the HIV and AIDS Response in Grenada: Investment Case Brief
 

Financial resource requirements 2012 2013

  • 1. Financial Resource Requirements 2012–2013 As as 1 February2012 of of 1 May 2012 PARTNERS IN THE GLOBAL POLIO ERADICATION INITIATIVE
  • 2. global polio eradication initiative © World Health Organization 2012 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index. html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Photo front cover: WHO/Frederic Caillet - Children in a polio-free India. On 12 January 2012, India passed the one year mark without polio for the first time in history. If all pending laboratory investigations return negative in the coming weeks, India will officially be deemed to have stopped indigenous wild poliovirus. The numbers of polio-endemic countries would be reduced to three: Pakistan, Afghanistan and Nigeria. Photo back cover: WHO/Sona Bari. Children during an SIA in March 2012 in Islamabad, Pakistan. Pakistan remains one of the three endemic countries. Persistent wild poliovirus transmission is restricted to three groups of districts: (1) Karachi city, (2) a group of districts in Balochistan Province, and (3) districts in the Federally Administered Tribal Areas (FATA) and the North-West Frontier Province. The Government of Pakistan and partners have launched an informative new website outlining the latest in the country’s polio eradication effort. The website is www.Endpolio.com.pk. Design: philippecasse.ch Layout: Paprika-annecy.com
  • 3. global polio eradication initiative 1 WHO/POLIO/12.04 Table of Contents 1 | Executive summary .......................................................................................................................3 2 | Financial Resource Requirements 2012-2013 .......................................................................6 3 | Roles and Responsibilities of Spearheading Partners . ...............................................7 4 | Definition of the GPEI Activities and Budget Estimates .................................................7 5 | Polio Research . ...........................................................................................................................14 6 | Review of the GPEI Budgets and Allocation of Funds . .................................................15 7 | Donors . ...........................................................................................................................................16 8 | Annexes ..........................................................................................................................................17 Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 4. 2 global polio eradication initiative Acronyms and abbreviations AusAID Australian Government Overseas Aid Program AFP Acute flaccid paralysis BMGF Bill & Melinda Gates Foundation bOPV Bivalent oral polio vaccine CDC US Centers for Disease Control and Prevention CIDA Canadian International Development Agency DFID UK Department for International Development EAP Global Polio Emergency Action Plan FRR Financial Resource Requirements GPEI Global Polio Eradication Initiative JICA Japan International Cooperation Agency mOPV Monovalent oral polio vaccine NIDs National Immunization Days OPV Oral polio vaccine PSC Programme support costs SIAs Supplementary Immunization Activities SNIDs Sub-national Immunization Days tOPV Trivalent oral polio vaccine UNICEF United Nations Children’s Fund USAID United States Agency for International Development VAPP Vaccine-associated paralytic polio VDPV Vaccine-derived poliovirus WHO World Health Organization WPV Wild poliovirus Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 5. global polio eradication initiative 3 1 | Executive summary The– Financial Resourcerequired andbycurrently(FRR) details the funding – Requirements series avail- able to finance activities identified the Global Polio While a new Global Polio Emergency Action Plan 2012- 2013 (EAP) is being developed to address the critical programmatic risks, urgent additional investments are Eradication Initiative (GPEI) for the 2012-2013 period essential to tip it towards success. With the lowest-ever to interrupt wild poliovirus transmission globally and number of polio cases reported for the first quarter of prepare for the post-eradication era. The FRR is updated 2012, in just four countries, success has never been quarterly. Programmatic and financial scenarios for the closer. polio eradication endgame (i.e. for 2014-2018) will be presented in an upcoming edition of the FRR. This edi- In January 2012, the WHO Executive Board declared that tion of the FRR summarizes financial developments in the the completion of polio eradication must now be treated past quarter in the relevant epidemiological context. as a “programmatic emergency for global public health.” Following this declaration the EAP has been developed, and will be discussed at the World Health Assembly in The 2012-2013 budget estimate for core costs, planned May 2012. The EAP represents an urgent escalation of supplementary immunization activities and emergency national and international efforts using a wide range of response is US$ 2.19 billion, against which there is a new targeted and cross-cutting initiatives to eradicate funding gap of US$ 945 million (US$ 270 million for polio, and enhanced resource mobilization to bridge the 2012). The Initiative is tracking US$ 344 million in firm Initiative’s critical funding gap. prospects; if donors fulfil these commitments, then the overall funding gap for 2012-2013 is reduced to US$ 601 The over-riding goal of the EAP is to help the remaining million. polio-infected areas of Nigeria, Pakistan and Afghanistan get back on track for eradication through an emergency The budget estimate of US$ 2.19 billion represents a approach with appropriate leadership, oversight and ac- decrease of US$ 44 million compared to earlier estimates, countability, and bolstered by an extensive surge of tech- driven primarily by the cancellation or reduction of nical assistance down to the subnational level. The emer- supplementary immunization activities (SIAs) in 24 high gency activities are driven by the national governments risk polio-free countries across west, central and the Horn of the endemic and re-established transmission countries, of Africa as well as Central Asia in the first half of 2012. with support from international partners. The EAP builds Additional cuts in SIAs will have to be instituted in the upon the approaches outlined in the GPEI Strategic Plan second half of 2012 should the required funding not be 2010-2012 and is designed to accelerate progress towards available. The revised budget estimate does include an the realization of its milestones. The EAP will also serve increase in surge capacity, primarily for Nigeria. New as a precursor to the endgame strategy for 2014-2018. contributions of US$ 98 million for 2012-2013, received since February 2012 from Angola, Bangladesh, Bill & In its February 2012 report, the Independent Monitoring Melinda Gates Foundation, Canada, Japan and Nigeria, Board of the GPEI (IMB) congratulated the Indian govern- help to offset this increase. ment and its partners on that country’s “magnificent” milestone.1 However, the IMB was extremely concerned at Table 1 | GPEI 2012-2013 Budget, as at May 2012 the increase in polio transmission in Nigeria and Pakistan, (all figures in US$ millions) stating that together, these two countries now constitute the most potent threat to global eradication. Budget, as at February 2,232.00 During its April meeting, the Strategic Advisory Group of Budget Decreases -44.00 Experts on immunization (SAGE) carefully reviewed the New Budget 2,188.00 country-specific national polio emergency action plans for Nigeria, Pakistan and Afghanistan. They expressed seri- Gap, as at February 1,089.00 ous alarm at the funding situation, and strongly appealed Budget Decreases -44.00 for donor and government support, highlighting that a continued funding crisis will rule out the full implemen- New Contributions -98.00 tation of the emergency plans. SAGE also requested the New Gap (Rounded) 945.00 polio partners to submit by November 2012 a strategic plan and budget for the 2014-2018 endgame period. In recent months, special efforts have been made to The Director-General of the World Health Organization recognize leaders in the fight to “End Polio Now.” On has described the current state of polio eradication as 14 March, United Kingdom (UK) Prime Minister David being at “a tipping point between success and failure.” Cameron was recognized by Rotary International as a 1 As of 28 February 2012, India is no longer considered to be a polio-endemic country. For the purposes of the current FRR, it is considered “recently-endemic”. 2 The Polio Eradication Champion Award is the highest honour Rotary presents to heads of state, health agency leaders and others who have made significant contributions to the global polio eradication effort. Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 6. 4 global polio eradication initiative Polio Eradication Champion2, for his leadership and dedi- The newly constituted Global Polio Partners’ Group cation to a polio-free world, and for announcing in 2011 (PPG) of GPEI, which serves as the “stakeholder voice” a doubling of the UK’s funding for the next two years in a in the polio program, met for the first time in Geneva challenge grant. “We have a once-in-a-generation oppor- on 11 April 2012. The meeting brought together do- tunity to rid the world of the evil of polio,” said Cameron nors and other financing and advocacy partners to dis- in a statement. “The commitment of Britain and the cuss the EAP, the IMB report and opportunities to close Global Polio Eradication Initiative, with the support of the critical funding gap. The PPG also discussed the millions of Rotarians, has helped bring this crippling and ongoing work around the polio eradication endgame often deadly disease to the brink of eradication.” plan for 2014-2018 as well as the long-term financing requirements and mechanisms. On 23 April, Rotary International’s incoming chair of the Rotary Foundation Board of Trustees, Wilfrid As the GPEI works with Governments to fully and effec- Wilkinson, presented Nigerian President Goodluck tively implement the EAP, additional funding is urgently Jonathan with the award in recognition of his contin- needed to close the funding gap of US$ 945 million to ued political and increasing financial support for polio conduct planned polio immunization activities in 2012- eradication. Nigeria has to date disbursed US$ 12.7 2013, and also support the longer term financing needs million of the US$ 30 million per year pledge made by for 2014-2018. The GPEI, through the Polio Advocacy President Jonathan at the October 2011 Commonwealth Group (PAG), seeks to work closely with all donors to Heads of Government meeting in Perth, Australia. mobilize the needed financial resources. In this regard, additional approaches will be made to the G8, the Rotarians and Rotary International continue to provide G20, the BRICS group of nations, member states of the extraordinary support, and in May announced that they Organization of Islamic Cooperation (OIC), multilateral had raised US$ 215 million towards the Bill & Melinda financial institutions and regional development banks, Gates Foundation’s US$ 200 million challenge. private citizens and the private sector. Table 2 | Summary of external resource requirements by major category of activity, 2012–2013 (all figures in US$ millions) CORE COSTS 2012 2013 2012-2013 Emergency Response (OPV) $16.50 $20.00 $36.50 Emergency Response (Ops) $40.00 $25.00 $65.00 Emergency Response (Soc Mob) $4.50 $6.00 $10.50 Surveillance and Running Costs (Incl. Security) $61.82 $64.36 $126.18 Surge Capacity $35.00 $0.00 $35.00 Laboratory $11.08 $11.23 $22.31 Technical Assistance (WHO) $134.04 $136.57 $270.61 Technical Assistance (UNICEF) $35.62 $37.31 $72.94 Certification and Containment $5.00 $5.00 $10.00 Product Development for OPV Cessation $10.00 $10.00 $20.00 Post-eradication OPV Stockpile $12.30 $0.00 $12.30 SUPPLEMENTARY IMMUNIZATION ACTIVITIES 2012 2013 2012-2013 Oral Polio Vaccine $301.73 $285.63 $587.36 NIDs/SNIDs Operations (WHO-Bilateral) $323.44 $248.39 $571.83 NIDs/SNIDs Operations (UNICEF) $28.33 $28.15 $56.48 Social Mobilization for SIAs $87.63 $93.68 $181.32 Subtotal $1 107.00 $971.32 $2 078.32 Programme Support Costs (estimated)* $56.98 $52.49 $109.47 GRAND TOTAL $1 163.98 $1 023.81 $2 187.79 Contributions $891.70 $349.11 $1 240.81 Funding Gap $272.28 $674.70 $946.98 Funding Gap (rounded) $270.00 $675.00 $945.00 * Programme Support Cost (PSC) estimates are calculated based on sources and channel of funds Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 7. global polio eradication initiative 5 Figure 1 | Annual expenditure 1988-2011, contributions and funding gap 2012-2013 (all figures in US$ millions) 1400 1200 1988-2011 Total expended: US$ 9.03 billion 1000 2012 800 Funding Gap: US$ 270 million 2013 Funding Gap: US$ 675 million 600 400 200 0 1988 1989 1990 1991 1992 19931993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 1988 1989 1990 1991 1992 EXPENDITURE CASH OR PLEDGED FUNDING GAP Figure 2 | Financing 2012-2013, US$1.24 billion contributions Financing 2012-2013, US$ 1.24 billion in contributions G8 14% Canada USAID CDC Multilateral JICA Loan Japan UK Russian Federation Sector 6% Conversion UNICEF EC WHO Bangladesh IFFIm India Domestic World Bank Resources 20% Private Bill & Melinda Gates Foundation Sector 15% Nigeria Rotary International Angola Australia Luxembourg Others Non-G8 OECD/ Other 2% Current Funding Gap: US$ 945 m of US$ 2.19 b budget Firm Prospects: US$ 344 m Best Case Gap: US$ 601 m ‘Other’ includes: Austria, Brunei Darussalam, Finland, Monaco, Nepal, Central Emergency Response Fund (CERF), Common Humanitarian Fund (South Sudan), and Google Foundation/Matching Grant. Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 8. 6 global polio eradication initiative 2 | Financial Resource Requirements 2012–2013 This Financial Resource Requirements (FRR) outlines The FRR is updated regularly based on evolving epide- the budget to implement the core strategies to stop miology; this is the second issue of the year3. Financial polio and to institutionalize innovations to improve the requirements detailed here represent country require- quality of intensified SIAs, increase technical assistance ments and are inclusive of agency (i.e. WHO and to countries with re-established polio transmission, UNICEF) overhead costs. enhance surveillance, systematize the synergies be- tween immunization systems and polio eradication and Endemic/recently-endemic countries account for 67% expand pre-planned vaccination campaigns across the of the country budgets; countries with re-established “WPV importation belt” of sub-Saharan Africa. Filling transmission for 15%; and, other importation-affected sub-national surveillance gaps, revitalizing surveillance countries for 18%. in polio-free Regions, implementing new global surveil- lance strategies and intensifying social mobilization Just as high-cost control of polio transmission is not work are also costed in the 2012–2013 budget. sustainable, low-cost control is not effective, since de- pending on routine immunization alone would lead to As the new Global Polio Emergency Action Plan 2012–2013 200,000–250,000 cases per year. Neither scenario is (EAP) is finalized, the Initiative is working under an optimal when eradication is feasible4. Previous cost-effec- emergency operating framework. The financial require- tiveness studies5 have demonstrated that US$ 10 billion ments outlined in this document reflect the strategic and would be needed over a 20-year period to simply geographic priorities of the framework as well as the maintain polio cases at current levels, in contrast to the continued implementation of key activities of the Strate- US$ 2.19 billion presented here. Financial modelling in gic Plan. The financial requirements incorporate the full 20106 estimated the financial benefits of polio eradica- scope of the Emergency Plan. tion at US$ 40–50 billion. Most of those savings (85%) are expected in low-income countries. Figure 3 | Comparison of budgets of countries conducting SIAs in 2012 (as a % of country-level costs) Polio-endemic/ Recently-endemic $350 countries 67% $300 34% $250 $200 $150 16% Re-established Countries with Other importation- 13% transmission recurrent importations affected countries 15% 16% 2% $100 12% $50 4% $0 i er lia nya nda nea nin ana oon gal l ar rde dia eria stan stan ngo gola had dan dan al ia re so en blic one eria ania ogo ngo sau bia esh epa In M Nig hiop 'Ivoi Fa ma i Be Gh er ene Yem epu Le Lib sc e g i i Ni Pak han R C o An C Su Su Ke Uga Gu rit T Co s Bi Gam gla d N ga e V h Et te d kina So am S R rra au ea da ap g D ut Ba n Af So Cô Bur C can Sie M uin M a C fri G lA tra C en 3 While the FRR provides overall budget estimates, detailed budgets are available upon request. 4 Barrett S, Economics of eradication vs control of infectious diseases, Bulletin of the WHO, Volume 82, Number 9, September 2004, 639-718. http://www.who.int/bul- letin/volumes/82/9/en/index.html 5 Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007; 369(9570): 1363-71. 6 Tebbens RD, et al. The Economic analysis of the global polio eradication initiative. Vaccine 2010, doi:10.1016/j.vaccine.2010.10.25.
  • 9. global polio eradication initiative 7 3 | Roles and Responsibilities of Spearheading Partners The spearheading partners of the GPEI are the World WHO is responsible for the systematic collection, colla- Health Organization (WHO), Rotary International, the tion and dissemination of standardized information on US Centers for Disease Control and Prevention (CDC) strategy implementation and impact, particularly in the and UNICEF Rotary International is the leading private- . areas of surveillance and supplementary immunization sector donor to polio eradication, advocates with govern- activities. ments and communities and provides field-level support in SIA implementation and social mobilization. CDC de- WHO also leads operational and basic research, pro- ploys a wide range of public health assistance in the form vides technical and operational support to ministries of of staff and consultants, provides specialized laboratory health, and coordinates training and deployment of hu- and diagnostic expertise and contributes funding. man resources for supplementary technical assistance. WHO also serves as secretariat to the certification UNICEF is the lead partner in support of communica- process and facilitates implementation and monitoring tions and social mobilization, and in the procurement of biocontainment activities. and distribution of oral polio vaccine for supplemen- tary immunization activities. UNICEF also works with The budgets that underpin the FRR are prepared by partners to strengthen routine immunization, including WHO, UNICEF and the national governments that support to cold chain and vaccine distribution mecha- manage the polio eradication activities. The funds to nisms at national and sub-national levels. finance the activities flow from multiple channels, primarily through these stakeholders. Both UN agen- cies support the governments in the preparation and implementation of SIAs. 4 | Definition of the GPEI Activities and Budget Estimates A robust system of estimating costs drives the develop- up for SIAs at the local level and take into consideration ment of the global budget estimates from the micro- local costs for all elements of an activity – trainings, level up. A schedule for SIAs is drawn up based on community meetings, posters, announcements, vaccina- the guidance of national Technical Advisory Groups tor payments, vehicles, fuel, supplies, etc. (TAGs), Ministries of Health and the country offices of WHO and UNICEF In 2011, for example, more than . 4.1. Cost Drivers of the GPEI Budget 2.35 billion doses of OPV were administered to more The key cost drivers of the GPEI budget are OPV and than 430 million children during 300 polio vaccination SIA operations, followed by technical assistance, social campaigns in 54 countries7. mobilization and surveillance8 (See Table 2). The recommended schedule of SIAs is used by national 4.1.1. Oral polio vaccine governments, working with WHO and UNICEF to de-, UNICEF is the agency that procures vaccine for the velop budget estimates. These are based on plans drawn GPEI, and works to ensure OPV supply security (with 7 In 2011, OPV was given during 144 National Immunization Days, 129 Sub-national Immunization Days, 10 mop-up campaigns and 17 Child Health Days. Children may have received more than one dose of OPV. 8 For 2012-2013, for example, OPV accounts for 29% of the budget, operations for 32%, technical assistance for 16%, social mobilization for 9% and surveillance for 6%, with the remainder being dedicated to emergency response, surge capacity, laboratories, research activities, etc. Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 10. 8 global polio eradication initiative multiple suppliers), at a price that is both affordable US$ 0.14 per dose since 2000. The flexibility of manu- to governments and donors and reasonably covers the facturers, to adjust production based on the OPV for- minimum needs of manufacturers. In 2011, more than mulation required, comes at a cost. Currency fluctua- 1.6 billion doses of OPV were required for activities in tions, the demand for high titres and the finite lifespan areas with active poliovirus transmission. of OPV – for which demand will drop after the eradica- tion of polio – also contribute to this price increase. Since 2005 the supply landscape has become more complex with the introduction of two types of monova- Despite these factors, the weighted average price of lent OPV (types 1 and 3) and, in 2010, bivalent OPV. each OPV dose in 2011 (US$ 0.128) and 2012 This has contributed to a rise in the weighted average (US$ 0.127) show decreases since 2010. price of OPV from US$ 0.08 per dose to approximately Figure 4 | OPV supply and weighted average price, 2000–2012 3,000 0.18 0.16 2,500 0.14 2,000 0.12 US$ PRICE PER DOSE MILLIONS DOSES 0.1 tOPV 1,500 0.08 mOPV1 1,000 0.06 mOPV3 0.04 500 0.02 bOPV 0 0 WAP 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 4.1.2. Operations costs Major factors affecting operations costs are the rela- SIAs are vast operations to deliver vaccine to every tive strength of the local infrastructure – whether it be household: micro-plans have to be drawn up or updat- roads, telecommunications or any of a host of facilities ed for every dwelling in the area to be covered, whether – and the local health system, the local economy, avail- a single district or an entire country. Vaccine has to be ability of semi-skilled workers, security conditions and delivered to distribution centres throughout the target population density. In 2011, 1.44 million paid vaccina- area. Vaccinators have to be trained to vaccinate chil- tors worked in SIAs; vaccinator per diems – to cover dren and mark fingers and houses, to document their basic needs such as food and transport – constitute a work, to report their activities, to communicate with large portion of operations costs9. families appropriately, and so on. Vaccinators have to visit every household; supervisors and monitors have to scour every street for unvaccinated children. 9 Based on local rates for semi-skilled labour and government remuneration for similar tasks. Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 11. global polio eradication initiative 9 Figure 5 | Operations costs per child for SIAs, 2012 (all figures in US$, excluding PSC) $ 1.00 $ 0.90 Polio-endemic/ Recently-endemic Re-established Countries with Other importation- countries transmission recurrent importations affected countries $ 0.80 $ 0.70 $ 0.60 $0.50 $ 0.40 $ 0.30 $ 0.20 $ 0.10 $ 0.00 sh ng al an Ta on m o a a Gu n da Ug li ire te so r pia Et ia So al Se o au a B ya bia Ga ia Li e ra ep. ca e nt Cap ania au o DR la An n ad n ut dia n ria Ni n ige a Ca Tog an ine ni ng on fri erd M ong da da ta a Ba Nep al r g go ine en M de Cô a Fa ist o an vo iss Ch be ist ge hio Be m ne Si n R So In kis er m Gh Co Le Bu N Su Su rit eV d'I jik Gu K la an C Pa in h gh rk er Af lA ra Ce 4.1.3. Surveillance Surveillance budgets cover the detection and reporting Some of the other activities included under surveil- of acute flaccid paralysis (AFP) cases, through both an lance budget lines are the training of personnel to carry extensive informant network of people who first report out each of the steps outlined above, as well as regular cases of AFP and active searches in health facilities for reviews of the surveillance systems and the purchase such cases. Subsequent case investigation is followed and maintenance of equipment, from photocopiers to by collection of two stool samples, transportation to vehicles. In locations where there are security risks for the appropriate laboratory, testing and genetic sequenc- polio staff, items such as armoured vehicles and appro- ing, the range of activities related to the management of priate communication equipment may be included in the information and data generated. The Global Polio the surveillance budgets. The average cost per AFP case Laboratory Network comprises 146 facilities, which in reported dropped from a high of more than US$ 1,500 2011 tested over 206,000 stool samples (from nearly in the year 2000, when there was heavy investment in 96,000 cases of AFP and other sources). establishing the infrastructure for AFP surveillance to ap- proximately US$ 581 in 2010. The range among coun- tries in cost per AFP case investigated is based on factors similar to those which affect differences in SIA costs. Financial Resource Requirements 2012–2013 | As of 1 may 2012
  • 12. 10 global polio eradication initiative Figure 6 | Surveillance cost per AFP case analysis, 2011 (all figures in US$)* $ 9,000 Other Polio-endemic/ importation- Recently-endemic Re-established Countries with affected countries transmission recurrent importations countries $ 6,000 $ 3,000 $0 l ea en ire a da a so i e a nin n go r pia ia p. ia ria o ad n la dia n an ria pa al ge ny ine on an oo ng da ta an al Re go itr M Fa m an vo To Ch ist be Ne ge hio Be In Ke kis Ni m er Le Gh Co Su Gu Er rit Ye An d'I Ug an n Li ina Ni So m Et Pa au ca ra DR te gh Ca rk fri er M Cô Af Bu lA Si ra nt Ce *Figures represent 80% of 2011 data. Figure 7 | Average cost per AFP case reported (AFR, EMR, SEAR) (all figures in US$)* 2,000 $ 1,711 1,500 $ 1,194 $ 1,096 $ 1,106 $ 1,128 1,000 $ 866 $ 815 $772 $ 741 $ 722 $ 692 $ 615 500 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 *Adjusted for inflation (2011 US$). Financial Resource Requirements 2012–2013 | As of 1 may 2012